AOD-9604 5mg | HGH Fragment 176-191 | 99% Purity | Third-Party Tested

Product Overview

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (HGH), specifically representing amino acids 176-191. This research-grade peptide has been extensively studied in laboratory settings for its molecular interactions with lipolytic pathways and adipocyte metabolism. AOD-9604 has been investigated as a modified HGH fragment that retains specific metabolic regulatory properties without full-spectrum growth hormone activity.

Our AOD-9604 research peptide is manufactured to the highest standards, with third-party verified purity exceeding 99%. Each vial contains 5mg of lyophilized (freeze-dried) peptide powder, accompanied by a Certificate of Analysis (COA) from an independent laboratory.

Research Applications

AOD-9604 has been the subject of numerous peer-reviewed studies examining its role as a modified HGH fragment. Research has focused on its molecular interactions with adipocyte lipolysis pathways, comparative analysis versus full-length growth hormone, and fragment-specific receptor binding mechanisms. Published studies have investigated AOD-9604’s molecular pathways in cell culture models and laboratory environments.

Research applications include:

• Lipolysis pathway studies: Examination of adipocyte triglyceride breakdown mechanisms and lipid metabolism regulation in vitro
• Fragment peptide analysis: Investigation of C-terminal HGH fragment activity, receptor selectivity, and structure-function relationships
• Metabolic signaling research: Study of cellular metabolic pathways, lipid mobilization mechanisms, and comparative fragment activity
• Peptide modification studies: Analysis of amino acid substitutions, molecular stability, and bioactivity retention in fragment peptides

Important: This product is intended for laboratory research use only. It is not approved for human consumption, clinical use, or any diagnostic or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease.

Product Specifications

• Peptide Name: AOD-9604
• Alternative Names: Advanced Obesity Drug 9604, HGH Fragment 176-191 (modified)
• Peptide Classification: Modified HGH C-terminal fragment
• Amino Acid Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (modified)
• Molecular Formula: C78H123N23O23S2
• Molecular Weight: 1815.1 g/mol
• Dosage per Vial: 5mg
• Form: Lyophilized (freeze-dried) white powder
• Purity: >99% (verified by third-party HPLC analysis)
• Storage: Store lyophilized peptide at -20°C. After reconstitution, store at 2-8°C and use within 30 days for optimal stability.
• Packaging: Sterile sealed vial with tamper-evident cap

Quality & Purity Guarantee

Every batch of our AOD-9604 peptide undergoes rigorous third-party testing to ensure maximum purity and quality:

• HPLC Analysis: High-Performance Liquid Chromatography confirms peptide purity >99%
• Mass Spectrometry: Verifies molecular weight and sequence accuracy
• Certificate of Analysis: Each order includes a COA from an independent, accredited laboratory
• Sterility Testing: Ensures product is free from microbial contamination
• Endotoxin Testing: Confirms safe levels for research applications

We are committed to providing researchers with the highest quality peptides for advancing scientific knowledge.

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is a modified synthetic peptide fragment derived from the C-terminal region (amino acids 176-191) of human growth hormone. It has been extensively studied in preclinical research settings as a fragment peptide that retains specific metabolic regulatory properties related to lipolysis and lipid metabolism pathways.

What is AOD-9604 used for in research?

AOD-9604 is used in laboratory research to study lipolysis mechanisms, adipocyte metabolism, and fragment peptide structure-function relationships. Research applications include lipid mobilization pathway analysis, comparative studies with full-length growth hormone, and metabolic signaling research. This product is for research purposes only and is not intended for human consumption.

How should AOD-9604 be stored?

Store lyophilized AOD-9604 at -20°C (freezer) for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C (refrigerator) and use within 30 days for optimal stability. Avoid repeated freeze-thaw cycles to maintain peptide integrity.

Does each vial come with a Certificate of Analysis?

Yes, every batch of our AOD-9604 peptide is tested by an independent, third-party laboratory. Each order includes access to the Certificate of Analysis (COA) verifying purity, molecular weight, and quality specifications through HPLC and mass spectrometry analysis.

How does AOD-9604 compare to full-length HGH in research?

AOD-9604 is a modified C-terminal fragment (176-191) of human growth hormone that has been studied for its selective retention of certain metabolic properties while lacking full-spectrum GH activity. Research applications focus on fragment-specific mechanisms, allowing researchers to study isolated lipolytic pathways without confounding effects from complete growth hormone receptor activation.

Can AOD-9604 be studied alongside other metabolic peptides?

Yes, AOD-9604 can be studied in comparative research settings alongside other metabolic peptides such as Semaglutide (GLP-1 agonist) and Tirzepatide (dual GIP/GLP-1 agonist) to examine differential metabolic pathway mechanisms. All research should be conducted in controlled laboratory environments by qualified personnel.

Research Disclaimer

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

This product is sold exclusively for research and laboratory purposes. AOD-9604 is not approved by the FDA for human use, clinical applications, or any diagnostic or therapeutic purposes when sold as a research peptide. This product is not intended to diagnose, treat, cure, or prevent any disease. Researchers should follow all applicable laws, regulations, and institutional guidelines when handling this material.

By purchasing this product, you acknowledge that you are a qualified researcher or acting on behalf of a research institution, and that this peptide will be used solely for in-vitro or laboratory research purposes.

Related Research Peptides

Researchers studying AOD-9604 may also be interested in these complementary peptides:

• Semaglutide (GLP-1 Receptor Agonist) – Incretin receptor agonist for comparative metabolic pathway research
• Tirzepatide (Dual GIP/GLP-1 Receptor Agonist) – Dual incretin agonist for metabolic mechanism studies
• CJC-1295 (Growth Hormone-Releasing Peptide) – GHRH analogue for growth hormone pathway research
• BPC-157 (Body Protection Compound-157) – Tissue research peptide with complementary molecular mechanisms